Essential role of MD-2 in LPS responsiveness and TLR4 distribution
Top Cited Papers
- 10 June 2002
- journal article
- research article
- Published by Springer Nature in Nature Immunology
- Vol. 3 (7) , 667-672
- https://doi.org/10.1038/ni809
Abstract
Toll-like receptor 4 (TLR4) mediates lipopolysaccharide (LPS) signaling in a variety of cell types. MD-2 is associated with the extracellular domain of TLR4 and augments TLR4-dependent LPS responses in vitro. We show here that MD-2−/− mice do not respond to LPS, do survive endotoxic shock but are susceptible to Salmonella typhimurium infection. We found that in MD-2−/− embryonic fibroblasts, TLR4 was not able to reach the plasma membrane and predominantly resided in the Golgi apparatus, whereas TLR4 was distributed at the leading edge surface of cells in wild-type embryonic fibroblasts. Thus, MD-2 is essential for correct intracellular distribution and LPS-recognition of TLR4.Keywords
This publication has 44 references indexed in Scilit:
- Innate Immune RecognitionAnnual Review of Immunology, 2002
- Human Toll-like receptor 4 recognizes host-specific LPS modificationsNature Immunology, 2002
- MD-2 and TLR4 N-Linked Glycosylations Are Important for a Functional Lipopolysaccharide ReceptorJournal of Biological Chemistry, 2002
- LBP, CD14, TLR4 and the murine innate immune response to a peritoneal Salmonella infectionInnate Immunity, 2001
- Cellular Events Mediated by Lipopolysaccharide-stimulated Toll-like Receptor 4Journal of Biological Chemistry, 2000
- The Toll-like Receptor Protein Rp105 Regulates Lipopolysaccharide Signaling in B CellsThe Journal of Experimental Medicine, 2000
- Plat-E: an efficient and stable system for transient packaging of retrovirusesGene Therapy, 2000
- Endotoxin-tolerant Mice Have Mutations in Toll-like Receptor 4 (Tlr4)The Journal of Experimental Medicine, 1999
- The Instructive Role of Innate Immunity in the Acquired Immune ResponseScience, 1996
- Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.The Journal of Experimental Medicine, 1992